arrow
N

Natalie K. Horvat

Emory University
H指数:9
被引数:658

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

一项XL888(HSP90抑制剂)与pembrolizumab联合治疗转移性胰腺癌的Phase Ib/II临床试验,并进行转化性免疫谱分析

2025-12-230
OAAI
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity

过继转输的Th17细胞与宿主B细胞协同作用,以实现持久的肿瘤免疫。

2025-07-240
OAAI
XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial

XL888和pembrolizumab在Ib/II期临床试验中调节结直肠癌的免疫景观。

2025-03-130
OA
Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment

超顺磁性氧化铁纳米颗粒可重新编程肿瘤微环境并减少克唑替尼治疗后的肺癌再生长

2024-04-165
OAAI
Phase Ib study of siltuximab and spartalizumab in advanced pancreatic cancer

siltuximab和spartalizumab治疗晚期胰腺癌的Ib期研究

2024-04-050
PRE
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
2023-02-1122
OAAI
Core Cross-Linked Polymeric Micelles for Specific Iron Delivery: Inducing Sterile Inflammation in Macrophages

用于特异性铁递送的核心交联聚合物胶束: 在巨噬细胞中诱导无菌炎症

2021-06-1623
OAAI